Cagrilintide is a synthetic amylin receptor agonist studied for its effects on appetite suppression and satiety signaling through a pathway distinct from GLP-1. It is sold strictly for Research Use Only and is not approved for human use.
Key Facts
| Classification | Synthetic amylin receptor agonist peptide |
| Molecular weight | 3,556 Da |
| Primary research focus | Appetite regulation and satiety-signaling models via the amylin pathway |
| Purity standard | ≥99%, HPLC and mass-spectrometry verified |
| Legal status | Research Use Only — not for human consumption |
What Is Cagrilintide?
Cagrilintide is a synthetic amylin analog studied for its role in appetite and satiety regulation. Amylin is a pancreatic hormone released alongside insulin that signals fullness and slows digestion — a pathway that is biologically distinct from GLP-1 signaling, even though both act on overlapping appetite centers in the brain.
Researchers studying both amylin and incretin-based satiety pathways may choose our product for its distinct, well-isolated receptor mechanism, which makes it useful for pathway-specific research designs.
How Does It Work?
In research models, Cagrilintide is studied for the following actions:
- Binds amylin receptors in the hypothalamic appetite centers
- Signals satiety through neural pathways distinct from GLP-1 signaling
- Slows gastric emptying, extending the feeling of fullness
- Supports secondary blood-glucose stabilization
- Associated with a 20–30% reduction in caloric intake in research models
What Effects Are Studied?
Appetite Suppression
Research models report appetite reduction in the 20–30% range, driven by POMC neuron activation, inhibition of appetite-stimulating signals, and slowed gastric emptying through amylin receptors rather than the GLP-1 pathway.
Satiety Duration
Cagrilintide is studied for producing a longer-lasting fullness signal after meals, along with reduced between-meal hunger and earlier meal termination.
Gastric Emptying
Slower gastric emptying is associated with more gradual glucose absorption and sustained satiety signaling, a shared feature with other satiety-pathway research but reached here through amylin activation.
Blood Sugar Support
Cagrilintide’s effect on blood sugar is indirect, arising from slower nutrient absorption and reduced caloric intake. Research models report HbA1c reductions of roughly 0.5–1%.
Featured Research Compound
Hotspan Cagrilintide — 99% verified purity, full COA, USA GMP manufacturing. See product specifications below or visit the Cagrilintide product page.
What Dosing Is Reported?
The following ranges reflect protocols described in published research models and are provided for research reference only.
- In vivo model dosing: starting dose 0.25–0.5mg/day, maintenance dose 0.5–1.0mg/day, with a maximum studied dose of 2.0mg/day; 8–12 week study durations are common; daily subcutaneous administration, or three times weekly at higher doses.
- In vitro dosing: 0.01–1 μM concentration range, with 0.1–0.5 μM as a typical working dose; 2–24 hour incubation periods; vehicle-only controls for baseline comparison.
- Conservative titration: many studies escalate gradually — 0.25mg/day for weeks 1–4, 0.5mg/day for weeks 5–8, 0.75–1.0mg/day from week 9 if needed — to monitor tolerance across dose escalation.
Quality Standards
All Hotspan research peptides, including Cagrilintide, are produced and verified against a single set of quality standards, summarized here and referenced throughout this guide and other product pages.
- Third-party HPLC analysis: confirms ≥99% purity and identifies degradation products.
- Mass spectrometry verification: confirms molecular weight (3,556 Da) and sequence accuracy.
- Endotoxin testing (LAL assay): verified to <5 EU/vial.
- USA GMP manufacturing: batch-to-batch consistency under regular facility inspection.
- Certificate of Analysis: chromatogram, mass-spec data, endotoxin results, batch number, and chemist sign-off provided with every batch.
Full documentation is available in the COA Library linked below.
Product Specifications
Product: Cagrilintide · Molecular weight: 3,556 Da · Purity: ≥99% (HPLC + mass spectrometry) · Form: lyophilized powder · Sterility: endotoxin-tested, <5 EU/vial. Full specifications, storage stability, and reconstitution details are available on the product page.
| Available Quantity | Purity | COA Reference | Price |
| 10mg vial | ≥99% | COA-CAG10 | $99 |
| Bulk / multi-vial | ≥99% | On request | Contact for pricing |
Storage and Stability
- Lyophilized (unopened): 12–24 months frozen at -20°C, 3–6 months refrigerated at 2–8°C, use within 2 weeks at room temperature.
- Reconstituted: 2–4 weeks refrigerated at 2–8°C, 3–6 months frozen at -20°C; minimize freeze-thaw cycles to preserve potency.
- Degradation factors: light exposure, heat, repeated freeze-thaw cycles, contamination, and pH shifts all reduce peptide stability.
FAQ
How quickly do effects appear in research models?
Appetite-related changes are reported within 24–48 hours. Measurable weight change is typically reported within 4–8 weeks, with maximum effects studied over 12+ weeks.
How does the amylin pathway differ from GLP-1 signaling?
Amylin and GLP-1 act on overlapping appetite centers through distinct receptors. Research models study amylin as a parallel, non-redundant pathway relevant to appetite-regulation research.
Is tolerance an issue in research models?
Early research suggests minimal tolerance over 12-month windows, though long-term data are still emerging for this newer compound.
What is a typical starting dose in research models?
Published protocols commonly start at 0.25–0.5mg/day, escalating to a 0.5–1.0mg/day maintenance range; 2.0mg/day is the highest dose studied and is rarely used.
How is research-grade Cagrilintide different from a prescription version?
Research-grade Cagrilintide is intended strictly for laboratory and in vitro use. A prescription version, where available, is FDA-regulated, physician-dosed, and offered through a separate medical program with its own supervision requirements.
How can I verify a batch’s quality?
Every batch ships with a Certificate of Analysis confirming ≥99% purity via HPLC, correct molecular weight via mass spectrometry, endotoxin below 5 EU/vial, and a chemist sign-off with batch traceability.
Related Resources
Research Use Only
Content on this page is for informational and educational purposes about peptide research. Products sold by Hotspan Labs are intended strictly for in vitro research and laboratory experimentation, not for human consumption or clinical application.